CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer - Wikidata - awgldk - TriplyDB

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

http://www.wikidata.org/entity/Q36245546

about

Towards tumor immunodiagnostics Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis Relevance of tumor-infiltrating lymphocytes in breast cancer Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis Clinical significance of tumor-infiltrating lymphocytes in breast cancer Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies Immune DNA signature of T-cell infiltration in breast tumor exomes.Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.Emerging therapies for breast cancer The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy.Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.Novel therapeutic strategies in the treatment of triple-negative breast cancer.Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.A review of the application of inflammatory biomarkers in epidemiologic cancer research.Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy.Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer.Intratumoral CD8⁺ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancer Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Colorectal Liver Metastasis: A Systematic Review and Meta-Analysis Identification and evaluation of network modules for the prognosis of basal-like breast cancer CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.Can pharmacological receptor tyrosine kinase inhibitors sensitize poor outcome breast tumors to immune-based therapies?Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for gliblastoma Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.Local iron homeostasis in the breast ductal carcinoma microenvironment.Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.The immune system and inflammation in breast cancer.

P2860

Q26738691-FB4A631E-7B36-45EC-9EB8-20A167CAFFCD Q26747792-D47B1585-B085-45EB-9CE0-6AC590ED6D84 Q26748691-4399886E-5099-41E2-B447-D43D8FD32300 Q26795598-459224E5-8833-4FEA-81E0-6C9E14C41BE1 Q26798074-F95C0029-1817-4118-9BFF-EB9D2846D98F Q27024810-5F7C6695-C7A5-4A82-BF89-FC644A6DABF8 Q28070214-EFF5A2CE-E4E9-4136-A788-28C70BD09214 Q30275647-97022356-10FE-473D-87CF-6EE3B020EDF8 Q30377226-9CE17987-548F-43E4-92BA-80E1823A3772 Q33584033-2D8209C3-717B-4F65-B0EB-D96A89D50EF6 Q33617949-0CB3C682-F13B-4731-AB44-95920A3C45E5 Q33660069-23B1F054-0E6A-472C-83E3-0606A35A4ADF Q33700800-BF994E4B-AEC5-4BBE-A3A0-F173EFF12473 Q33829684-8D3ED431-6950-4C2A-8307-BE1AFE79FCA5 Q33850657-955CB603-9723-44C2-BC27-7AF1F473A156 Q33887682-8FF77B8A-20EB-40B7-872A-1C3CE9843E96 Q33916814-B274D7CB-384C-42ED-89E9-6FB712F07F77 Q34135803-248FC852-3C78-4628-88A8-FA75511C27B1 Q34172008-7CDF1541-5503-4145-8EC5-3DFAAAE55F7D Q34337667-62A15DE6-C7E8-4E49-B517-DCEACD79D795 Q34447829-733A501D-42B5-4D71-80FE-B880E3F7AF8C Q34789746-F5894BF5-7F23-41E7-BA7B-40A4B2F9AEA5 Q34988382-8C2F0301-E49D-4D62-8555-8A030BD9B103 Q35000238-A7ADA0C8-42A5-4B02-A823-AA473AF03A3E Q35009369-60590795-8190-48F7-AACB-6DB627D5E6D4 Q35151735-9D6AF896-422A-40E2-BAFA-93F5D9D9F3CE Q36030405-A3597404-AFD0-4472-8660-E12643E072B6 Q36079922-63945960-894A-4DF1-9FF5-7ED11127AACC Q36232146-708E0870-7D4B-4088-8FE2-5D2700DF0304 Q36413180-2F57ED22-6C0F-49DD-AA57-E5B0F2F07B12 Q36547888-B31B1A02-6FD3-4FD8-B630-18D553B70FE5 Q36557847-11A45087-3F0E-4D3F-9DD5-E0D3A55172AF Q36605526-DC4160B2-6F39-4174-B044-57F6A71F9504 Q36609839-22554CBD-8070-4EF9-83A8-004F8CA86E5E Q36630430-3ECB3903-3B0C-4206-ABAA-37D5F0A89825 Q36654277-8BBF6681-9FAD-4B29-82B8-A88625923F8B Q36772903-E66BB3B6-2AB9-4F20-900E-C9637D5B9E8E Q36778827-C728D578-AB96-4B3F-A528-CF8B2B503E20 Q36997687-D45C70FC-1409-4016-966E-1F10B4A44F68 Q37033451-8866CB49-37D4-4C46-9DB5-D97E75B1E531

P2860

CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer

http://www.wikidata.org/entity/Q36245546

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

CD8+ lymphocyte infiltration i ...... or in basal-like breast cancer

@ast

CD8+ lymphocyte infiltration i ...... or in basal-like breast cancer

@en

type

label

CD8+ lymphocyte infiltration i ...... or in basal-like breast cancer

@ast

CD8+ lymphocyte infiltration i ...... or in basal-like breast cancer

@en

prefLabel

CD8+ lymphocyte infiltration i ...... or in basal-like breast cancer

@ast

CD8+ lymphocyte infiltration i ...... or in basal-like breast cancer

@en

P1433

Q36245546-87F5F257-02FF-4593-8CF9-147EED236890

P1476

Q36245546-7F5CF945-9794-49BE-96C1-9A0BF523630F

P2093

Q36245546-30778417-5A0F-4A67-90B4-93871314BB1A

Q36245546-47948664-192B-4CFB-8362-10AFEF41799E

Q36245546-65B35B0F-1929-46A2-9A77-F88B5CEE80F3

Q36245546-8F5CB5DA-AC8F-440B-B284-1F02494FF770

Q36245546-BFAC6027-09F8-4DA4-9F10-70EF62612A33

P2860

Q36245546-06F2FB25-DCC7-406A-B57F-D01327FD97C3

Q36245546-0B891C31-B456-43D8-868C-A472F907AB85

Q36245546-1445B291-0617-4247-837B-6E079AFA4A6F

Q36245546-1AC3DF98-17F1-40EA-BE38-6ED961F18714

Q36245546-1E2521CB-0900-45BE-A248-4BA96A0E74C8

Q36245546-21C12622-FEB5-4FCD-8AB1-D01F3C4677FA

Q36245546-248E03E4-D697-4B33-BDC4-731FD46BEA8F

Q36245546-26D664F0-F1E2-4483-BD0E-72DF2894649E

Q36245546-2874AF39-1592-461B-BE0D-8FCE4EC4A5F9

Q36245546-28E34F28-3B07-4EBC-8592-8FD08DC20C16

P2888

Q36245546-2D252F76-8243-4193-BC7B-8A7EC930B7AF

P304

Q36245546-E6DA875E-67ED-4E02-949F-1FA66DEC1C74

P31

Q36245546-4E6BFB66-2032-4A4F-82B4-8A92782CCE73

P356

Q36245546-A5FA9F9F-A010-4FE2-9361-94AE7C7E35FD

P433

Q36245546-37975C3B-6E2F-4CB5-9669-CC1A8DFF59D9

P478

Q36245546-430D2C33-06ED-48FE-A6D0-C7EC1E8744CE

P50

Q36245546-BAB6D769-7219-49D4-9AE9-2D5A2BA398C5

P577

Q36245546-EAD5B912-2019-4134-AE89-D362B3277C3D

P5875

Q36245546-A6090B8C-8F49-4E6D-9BF7-9AC019588678

P6179

Q36245546-E318AAA0-B8C6-4BA8-A855-360E7CEA7E62

P698

Q36245546-E83D872B-E4BE-49CF-A8DC-C17609E944FF

P932

Q36245546-43038356-EB3D-450F-8D81-65A46E2BD483

P356

P1433

Breast Cancer Research

P1476

CD8+ lymphocyte infiltration i ...... or in basal-like breast cancer

@en

P2093

Dongxia Gao

http://www.w3.org/2001/XMLSchema#string

Jonathan Lachapelle

http://www.w3.org/2001/XMLSchema#string

Samuel Leung

http://www.w3.org/2001/XMLSchema#string

Shuzhen Liu

http://www.w3.org/2001/XMLSchema#string

Torsten O Nielsen

http://www.w3.org/2001/XMLSchema#string

P2860

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Macrophage diversity enhances tumor progression and metastasis

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules

A pathway-based classification of human breast cancer.

Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer.

P2888

P304

R48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR3148

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

William D Foulkes

P577

2012-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221707888

http://www.w3.org/2001/XMLSchema#string

P6179

1014237989

http://www.w3.org/2001/XMLSchema#string

P698

22420471

http://www.w3.org/2001/XMLSchema#string

P932

3446382

http://www.w3.org/2001/XMLSchema#string